Characterization of clonogenic multiple myeloma cells

作者: William Matsui , Carol Ann Huff , Qiuju Wang , Matthew T. Malehorn , James Barber

DOI: 10.1182/BLOOD-2003-09-3064

关键词: Clonogenic assayStem cellImmunophenotypingBiologyCD40Cell cultureAntigenSevere combined immunodeficiencyCellMolecular biology

摘要: The identity of the cells responsible for initiation and maintenance multiple myeloma (MM) remains unclear largely because difficulty growing MM in vitro vivo. cell lines clinical specimens are characterized by malignant plasma that express surface antigen syndecan-1 (CD138); however, CD138 expression is limited to terminally differentiated during B-cell development. Moreover, circulating B clonally related have been reported some patients with MM. We found human contained small (< 5%) subpopulations lacked had greater clonogenic potential than corresponding CD138+ cells. CD138- from samples were similarly both nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, whereas not. Furthermore, phenotypically resembled postgerminal center cells, their growth was inhibited anti-CD20 monoclonal antibody rituximab. These data suggest “stem cells” ability replicate subsequently differentiate into

参考文章(51)
Linda M. Pilarski, Gail Hipperson, Karen Seeberger, Eva Pruski, Robert W. Coupland, Andrew R. Belch, Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood. ,vol. 95, pp. 1056- 1065 ,(2000) , 10.1182/BLOOD.V95.3.1056.003K26_1056_1065
A Bedi, BA Zehnbauer, MI Collector, JP Barber, MS Zicha, SJ Sharkis, RJ Jones, BCR-ABL Gene Rearrangement and Expression of Primitive Hematopoietic Progenitors in Chronic Myeloid Leukemia Blood. ,vol. 81, pp. 2898- 2902 ,(1993) , 10.1182/BLOOD.V81.11.2898.2898
Gaëtan Jego, Nelly Robillard, Denis Puthier, Martine Amiot, Françoise Accard, Danielle Pineau, Jean-Luc Harousseau, Régis Bataille, Catherine Pellat-Deceunynck, Reactive Plasmacytoses Are Expansions of Plasmablasts Retaining the Capacity to Differentiate Into Plasma Cells Blood. ,vol. 94, pp. 701- 712 ,(1999) , 10.1182/BLOOD.V94.2.701.414K16_701_712
Chuan-Ing Yeoh, Shieh-Ching Yang, Pulmonary function impairment in pneumoconiotic patients with progressive massive fibrosis. Chang Gung medical journal. ,vol. 25, pp. 72- 80 ,(2002)
A Bedi, BA Zehnbauer, JP Barber, SJ Sharkis, RJ Jones, Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood. ,vol. 83, pp. 2038- 2044 ,(1994) , 10.1182/BLOOD.V83.8.2038.2038
Joshua Epstein, MYELOMA STEM CELL PHENOTYPE: Implications For Treatment Hematology-oncology Clinics of North America. ,vol. 11, pp. 43- 49 ,(1997) , 10.1016/S0889-8588(05)70414-7
Linda M. Pilarski, Gitte S. Jensen, Monoclonal Circulating B Cells in Multiple Myeloma Hematology/Oncology Clinics of North America. ,vol. 6, pp. 297- 322 ,(1992) , 10.1016/S0889-8588(18)30346-0
Ivan Van Riet, Karin Vanderkerken, Angelo Willems, Benjamin Van Camp, Kewal Asosingh, Delayed in vivo disease progression is associated with high proportions of CD45+ myeloma cells in the 5T2MM murine model. Cancer Research. ,vol. 63, pp. 3019- 3020 ,(2003)
B Drewinko, R Alexanian, H Boyer, B Barlogie, SI Rubinow, The growth fraction of human myeloma cells Blood. ,vol. 57, pp. 333- 338 ,(1981) , 10.1182/BLOOD.V57.2.333.333